Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Schett

Showing results (851-860 of 908) with videos related to

Pageof 91
Sort By:
Nature Medicine|February 12, 2013
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitusStefan Kiechl, Jürgen Wittmann, Andrea Giaccari, et al.
Annals of the Rheumatic Diseases|October 21, 2015
Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatmentJuergen Rech, Axel J Hueber, Stephanie Finzel, et al.
Arthritis Care & Research|November 5, 2011
Determinants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activityNasim A Khan, Horace J Spencer, Esam Abda, et al.
Nature Metabolism|July 23, 2020
Author Correction: Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signalingMartina Rauner, Ulrike Baschant, Antonella Roetto, et al.
Eclinicalmedicine|February 16, 2024
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committeeRaffaella Greco, Tobias Alexander, Nicoletta Del Papa, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory DiseaseRebecca H Haberman, Ramin Sedaghat Herati, David Simon, et al.
The Lancet. Rheumatology|June 26, 2025
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 studyAndreas Hess, Koray Tascilar, Hanna M Schenker, et al.
The New England Journal of Medicine|February 21, 2024
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-upFabian Müller, Jule Taubmann, Laura Bucci, et al.
Annals of the Rheumatic Diseases|June 22, 2016
Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugsCamille P Figueiredo, Holger Bang, Jayme Fogagnolo Cobra, et al.
RMD Open|August 8, 2022
Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task forcePavel V Ovseiko, Laure Gossec, Laura Andreoli, et al.
Pageof 91

Showing results (851-860 of 908) with videos related to

Sort By:
Pageof 91
Nature Medicine|February 12, 2013
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitusStefan Kiechl, Jürgen Wittmann, Andrea Giaccari, et al.
Annals of the Rheumatic Diseases|October 21, 2015
Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatmentJuergen Rech, Axel J Hueber, Stephanie Finzel, et al.
Arthritis Care & Research|November 5, 2011
Determinants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activityNasim A Khan, Horace J Spencer, Esam Abda, et al.
Nature Metabolism|July 23, 2020
Author Correction: Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signalingMartina Rauner, Ulrike Baschant, Antonella Roetto, et al.
Eclinicalmedicine|February 16, 2024
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committeeRaffaella Greco, Tobias Alexander, Nicoletta Del Papa, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory DiseaseRebecca H Haberman, Ramin Sedaghat Herati, David Simon, et al.
The Lancet. Rheumatology|June 26, 2025
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 studyAndreas Hess, Koray Tascilar, Hanna M Schenker, et al.
The New England Journal of Medicine|February 21, 2024
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-upFabian Müller, Jule Taubmann, Laura Bucci, et al.
Annals of the Rheumatic Diseases|June 22, 2016
Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugsCamille P Figueiredo, Holger Bang, Jayme Fogagnolo Cobra, et al.
RMD Open|August 8, 2022
Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task forcePavel V Ovseiko, Laure Gossec, Laura Andreoli, et al.
Pageof 91